157 related articles for article (PubMed ID: 37913780)
1. Intratracheal Instillation of Budesonide-Surfactant for Prevention of Bronchopulmonary Dysplasia in Extremely Premature Infants.
Dolma K; Zayek M; Gurung A; Eyal F
Am J Perinatol; 2024 May; 41(S 01):e3065-e3073. PubMed ID: 37913780
[TBL] [Abstract][Full Text] [Related]
2. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
[TBL] [Abstract][Full Text] [Related]
3. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
Trials; 2023 May; 24(1):320. PubMed ID: 37161488
[TBL] [Abstract][Full Text] [Related]
4. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
5. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Walker E; Osborn DA
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182
[TBL] [Abstract][Full Text] [Related]
6. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
van de Loo M; van Kaam A; Offringa M; Doyle LW; Cooper C; Onland W
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013271. PubMed ID: 38597338
[TBL] [Abstract][Full Text] [Related]
8. Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.
Yeh TF; Chen CM; Wu SY; Husan Z; Li TC; Hsieh WS; Tsai CH; Lin HC
Am J Respir Crit Care Med; 2016 Jan; 193(1):86-95. PubMed ID: 26351971
[TBL] [Abstract][Full Text] [Related]
9. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
[TBL] [Abstract][Full Text] [Related]
10. Intra-tracheal surfactant/budesonide versus surfactant alone: Comparison of two consecutive cohorts of extremely preterm infants.
Moschino L; Nardo D; Bonadies L; Stocchero M; Res G; Priante E; Salvadori S; Baraldi E
Pediatr Pulmonol; 2021 Jul; 56(7):2114-2124. PubMed ID: 33942570
[TBL] [Abstract][Full Text] [Related]
11. Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia.
Heo M; Jeon GW
Turk J Pediatr; 2020; 62(4):551-559. PubMed ID: 32779407
[TBL] [Abstract][Full Text] [Related]
12. The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial.
Marzban A; Mokhtari S; Tavakkolian P; Mansouri R; Jafari N; Maleki A
BMC Pediatr; 2024 Apr; 24(1):262. PubMed ID: 38643076
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: A systematic review and meta-analysis.
Zhang M; Zhang W; Liao H
Respir Med Res; 2024 Jun; 85():101096. PubMed ID: 38744231
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy of pulmonary surfactant combined with budesonide for preventing bronchopulmonary dysplasia in very low birth weight infants].
Pan J; Chen MW; Ni WQ; Fang T; Zhang H; Chen Y; Pan JH
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Feb; 19(2):137-141. PubMed ID: 28202108
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of intratracheal administration of budesonide combined with pulmonary surfactant in preventing bronchopulmonary dysplasia: a prospective randomized controlled trial.
Liu MM; Ji L; Dong MY; Zhu XF; Wang HJ
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jan; 24(1):78-84. PubMed ID: 35177180
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis.
Tang W; Chen S; Shi D; Ai T; Zhang L; Huang Y; Fan Y; Du Y
Pediatr Pulmonol; 2022 Feb; 57(2):455-469. PubMed ID: 34783192
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia.
Gharehbaghi MM; Ganji S; Mahallei M
Oman Med J; 2021 Jul; 36(4):e289. PubMed ID: 34447583
[TBL] [Abstract][Full Text] [Related]
18. Long-term Effects of Intratracheal Budesonide and Surfactant for the Prevention of Bronchopulmonary Dysplasia: A Narrative Review.
Nobile S; Di Sipio Morgia C; Hall M
Am J Perinatol; 2024 May; 41(S 01):e1858-e1865. PubMed ID: 37279790
[TBL] [Abstract][Full Text] [Related]
19. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
[TBL] [Abstract][Full Text] [Related]
20. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
[No Abstract] [Full Text] [Related]
[Next] [New Search]